Original language | English |
---|---|
Pages (from-to) | 340-343 |
Number of pages | 4 |
Journal | Haematologica |
Volume | 102 |
Issue number | 9 |
DOIs | |
State | Published - 31 Aug 2017 |
Externally published | Yes |
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Haematologica, Vol. 102, No. 9, 31.08.2017, p. 340-343.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia
T2 - A report from the Children’s Oncology Group
AU - Miller, Tamara P.
AU - Li, Yimei
AU - Kavcic, Marko
AU - Getz, Kelly D.
AU - Huang, Yuan Shun V.
AU - Sung, Lillian
AU - Alonzo, Todd A.
AU - Gerbing, Robert
AU - Daves, Marla H.
AU - Horton, Terzah M.
AU - Pulsipher, Michael A.
AU - Pollard, Jessica
AU - Bagatell, Rochelle
AU - Seif, Alix E.
AU - Fisher, Brian T.
AU - Luger, Selina
AU - Gamis, Alan S.
AU - Adamson, Peter C.
AU - Aplenc, Richard
N1 - Funding Information: 1Divisions of Oncology, The Children’s Hospital of Philadelphia, PA, USA;2Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, PA, USA;3Department of Biomedical and Health Informatics, The Children’s Hospital of Philadelphia, PA, USA; 4Center for Clinical Epidemiology and Biostatistics Departments of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA;5Department of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada;6Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA;7Children’s Oncology Group, Monrovia, CA, USA;8Department of Pediatrics, Section of Hematology-Oncology, Texas Children’s Hospital, Houston, TX, USA;9Division of Hematology, Oncology and BMT, Children’s Hospital of Los Angeles, USC Keck School of Medicine, CA, USA; 10Maine Children’s Cancer Program, Maine Medical Center, Scarborough, ME, USA;11Departments of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA;12Infectious Diseases, The Children’s Hospital of Philadelphia, PA, USA; 13Hematology/Bone Marrow Transplant, University of Pennsylvania School of Medicine, Philadelphia, PA, USA and 14Pediatric Hematology/Oncology, Children’s Mercy Hospital, Kansas City, MO, USA Fundind: this work is supported by the National Institutes of Health R01 CA165277, K12 CA076931, Statistics and Data Center Grant U10CA098413, Chair's Grant U10CA098543, National Clinical Trials Network (NCTN) Operations Center Grant U10CA180886, NCTN Statistics & Data Center U10CA180899, the Pediatric Pharmacoepidemiology Training Grant 5T32HD064567-04, the Damon Runyon Cancer Research Foundation, and the St. Baldrick’s Foundation. Staci Arnold, MD, MBA, Jessica Bokland, MD, James Feusner, MD, Samir Kahwash, MD, Michael Kelly, MD, PhD, Matthew Kutny, MD, William Roberts, MD, and Naomi Winick, MD also contributed data for this manuscript. Correspondence: aplenc@email.chop.edu doi:10.3324/haematol.2017.168815 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.
PY - 2017/8/31
Y1 - 2017/8/31
UR - http://www.scopus.com/inward/record.url?scp=85029581914&partnerID=8YFLogxK
U2 - 10.3324/haematol.2017.168815
DO - 10.3324/haematol.2017.168815
M3 - Letter
C2 - 28642300
AN - SCOPUS:85029581914
SN - 0390-6078
VL - 102
SP - 340
EP - 343
JO - Haematologica
JF - Haematologica
IS - 9
ER -